EMILY CRANDELL: Open Payments
NPI 1114476231 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,784 in 83 payments from 19 companies in 2025. Trend: 2023 $1,254 · 2024 $1,209 · 2025 $1,784
Food & beverage: $1,734Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $392 |
| GlaxoSmithKline, LLC. | 7 | $195 |
| Abbott Laboratories | 9 | $157 |
| Otsuka America Pharmaceutical, Inc. | 5 | $131 |
| ALK-Abello, Inc | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| Corcept Therapeutics | 3 | $80 |
| PFIZER INC. | 4 | $79 |
| Exact Sciences Corporation | 3 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
Products named: VRAYLAR, REXULTI, Odactra, FREESTYLE LIBRE 3, AREXVY, TRELEGY ELLIPTA, JARDIANCE, Korlym.
Industry payments across NY — which companies pay providers there.
